Treatment of hypertension in patients undergoing coronary artery by-pass grafting

Mehta, 2008, Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry, Eur Heart J, 29, 3052, 10.1093/eurheartj/ehn478 Pivatto Júnior, 2011, Long-term survival of octogenarian patients submitted to isolated coronary artery bypass graft surgery, Rev Bras Cir Cardiovasc, 26, 21, 10.1590/S0102-76382011000100007 Pierri, 2010, The changing face of cardiac surgery patients: an insight into a Mediterranean region, Eur J Cardiothorac Surg, 38, 407, 10.1016/j.ejcts.2010.02.040 Aldea, 2009, Changing volumes, risk profiles, and outcomes of coronary artery bypass grafting and percutaneous coronary interventions, Ann Thorac Surg, 87, 1828, 10.1016/j.athoracsur.2009.03.067 Boatman, 2009, Prior coronary artery bypass graft surgery patients undergoing diagnostic coronary angiography have multiple uncontrolled coronary artery disease risk factors and high risk for cardiovascular events, Heart Vessels, 24, 241, 10.1007/s00380-008-1114-1 Müller-Nordhorn, 2008, Blood pressure control in the year following coronary events, Int J Cardiol, 130, 205, 10.1016/j.ijcard.2007.08.042 Okrainec, 2006, Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry, Can J Cardiol, 22, 841, 10.1016/S0828-282X(06)70302-6 Goyal, 2007, Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery, Ann Thorac Surg, 83, 993, 10.1016/j.athoracsur.2006.10.046 Tarakji, 2011, Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting, JAMA, 305, 381, 10.1001/jama.2011.37 Kasai, 2009, The adverse prognostic significance of the metabolic syndrome with and without hypertension in patients who underwent complete coronary revascularization, J Hypertens, 27, 1017, 10.1097/HJH.0b013e32832961cf Tadic, 2011, Predictors of atrial fibrillation following coronary artery bypass surgery, Med Sci Monit, 17, CR48, 10.12659/MSM.881329 Brown, 2007, Multivariable prediction of renal insufficiency developing after cardiac surgery, Circulation, 116, I139, 10.1161/CIRCULATIONAHA.106.677070 Salehi Omran, 2007, Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality, BMC Infect Dis, 7, 112, 10.1186/1471-2334-7-112 Herlitz, 1999, Mortality, risk indicators, mode and place of death and symptoms of angina pectoris in the five years after coronary artery bypass grafting in patients with and without a history of hypertension, Blood Press, 8, 200, 10.1080/080370599439571 Aronson, 2002, Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery, Anesth Analg, 94, 1079, 10.1097/00000539-200205000-00005 Karimi, 2008, Factors affecting postoperative morbidity and mortality in isolated coronary artery bypass graft surgery, Surg Today, 38, 890, 10.1007/s00595-007-3733-z Denardo, 2010, Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]), Am J Cardiol, 106, 498, 10.1016/j.amjcard.2010.03.056 Graham, 2007, Eur Heart J, 28, 2375, 10.1093/eurheartj/ehm316 Fox, 2006, Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology, Eur Heart J, 27, 1341, 10.1093/eurheartj/ehl001 Kojuri, 2009, Ability of amiodarone and propranolol alone or in combination to prevent post-coronary bypass atrial fibrillation, Cardiovasc Ther, 27, 253, 10.1111/j.1755-5922.2009.00100.x Coleman, 2004, Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation, Ann Pharmacother, 38, 2012, 10.1345/aph.1E310 Marazzi, 2011, Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure, Am J Cardiol, 107, 215, 10.1016/j.amjcard.2010.08.062 Acikel, 2008, Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery, Int J Cardiol, 126, 108, 10.1016/j.ijcard.2007.03.123 Dobrilovic, 2005, Diltiazem prophylaxis reduces incidence of atrial fibrillation after coronary artery bypass grafting, J Cardiovasc Surg (Torino), 46, 457 White, 2007, Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III, Eur J Cardiothorac Surg, 31, 817, 10.1016/j.ejcts.2007.02.010 Shariff, 2010, Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery, BMC Cardiovasc Disord, 10, 7, 10.1186/1471-2261-10-7 Rader, 2010, Preoperative angiotensin-blocking drug therapy is not associated with atrial fibrillation after cardiac surgery, Am Heart J, 160, 10.1016/j.ahj.2010.05.033 Halonen, 2006, Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery, Circulation, 114, I1, 10.1161/CIRCULATIONAHA.105.000851 Krzych, 2009, Rationale for propofol use in cardiac surgery, J Cardiothorac Vasc Anesth, 23, 878, 10.1053/j.jvca.2009.05.001 Krzych, 2011, Perioperative blood pressure variability in patients undergoing coronary artery bypass grafting: its magnitude and determinants, Blood Press Monit, 16, 129, 10.1097/MBP.0b013e328346d69f Okrainec, 2005, Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials, J Am Coll Cardiol, 45, 177, 10.1016/j.jacc.2004.09.065 Filion, 2007, Perioperative use of cardiac medical therapy among patients undergoing coronary artery bypass graft surgery: a systematic review, Am Heart J, 154, 407, 10.1016/j.ahj.2007.04.036 European Association for Percutaneous Cardiovascular Interventions (EAPCI), 2010, Guidelines on myocardial revascularization, Eur J Cardiothorac Surg, 38, S1 Sleilaty, 2009, Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: a prospective randomized trial, Int J Cardiol, 137, 116, 10.1016/j.ijcard.2008.06.034 Halonen, 2010, Metoprolol versus amiodarone in the prevention of atrial fibrillation after cardiac surgery: a randomized trial, Ann Intern Med, 153, 703, 10.7326/0003-4819-153-11-201012070-00003 European Association for Cardio-Thoracic Surgery, 2010, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur Heart J, 31, 2369, 10.1093/eurheartj/ehq278 Tamura, 2010, Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation, Gen Thorac Cardiovasc Surg, 58, 120, 10.1007/s11748-009-0544-8 Sun, 2011, Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting, Int Heart J, 52, 7, 10.1536/ihj.52.7 Behmanesh, 2006, Effect of prophylactic bisoprolol plus magnesium on the incidence of atrial fibrillation after coronary bypass surgery: results of a randomized controlled trial, Curr Med Res Opin, 22, 1443, 10.1185/030079906X115649 Shepherd, 2008, Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation, Health Technol Assess, 12, 10.3310/hta12280 Felker, 2011, Diuretic strategies in patients with acute decompensated heart failure, N Engl J Med, 364, 797, 10.1056/NEJMoa1005419 Aronow, 2011, J Am Soc Hypertens, 5, 259, 10.1016/j.jash.2011.06.001 van Haelst, 2003, Long term angiotensin converting enzyme-inhibition in patients after coronary artery bypass grafting reduces levels of soluble intercellular cell adhesion molecule-1, Eur J Vasc Endovasc Surg, 26, 387, 10.1016/S1078-5884(03)00084-4 Radaelli, 2007, Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination, Arterioscler Thromb Vasc Biol, 27, 2750, 10.1161/ATVBAHA.107.149039 Rouleau, 2008, Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery, Circulation, 117, 24, 10.1161/CIRCULATIONAHA.106.685073 Miceli, 2009, Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting, J Am Coll Cardiol, 54, 1778, 10.1016/j.jacc.2009.07.008 Westenbrink, 2011, Sustained postoperative anaemia is associated with an impaired outcome after coronary artery bypass graft surgery: insights from the IMAGINE trial, Heart, 97, 1590, 10.1136/heartjnl-2011-300118 Ripamonti, 2006, Angiotensin-converting enzyme inhibitors slow recovery from anemia following cardiac surgery, Chest, 130, 79, 10.1378/chest.130.1.79 Oosterga, 2001, Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia, Am J Cardiol, 87, 542, 10.1016/S0002-9149(00)01428-4 Wagner, 2003, Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction, Crit Care Med, 31, 1421, 10.1097/01.CCM.0000063050.66813.39 Benedetto, 2008, Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting, Ann Thorac Surg, 86, 1160, 10.1016/j.athoracsur.2008.06.018 Benedetto, 2008, Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery, J Cardiovasc Med (Hagerstown), 9, 1098, 10.2459/JCM.0b013e32830a6daf Völzke, 2002, Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery, Chest, 122, 31, 10.1378/chest.122.1.31 Ragia, 2010, Renin-angiotensin-aldosterone system gene polymorphisms in coronary artery bypass graft surgery patients, J Renin Angiotensin Aldosterone Syst, 11, 136, 10.1177/1470320310361742 Shahzamani, 2009, The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study, J Cardiovasc Pharmacol Ther, 14, 185, 10.1177/1074248409341879 Mancia, 2007, 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), J Hypertens, 25, 1105, 10.1097/HJH.0b013e3281fc975a Mancia, 2009, Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document, J Hypertens, 27, 2121, 10.1097/HJH.0b013e328333146d Mann, 2011, Drug therapy for resistant hypertension: simplifying the approach, J Clin Hypertens (Greenwich), 13, 120, 10.1111/j.1751-7176.2010.00387.x Gupta, 2010, Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis, Hypertension, 55, 399, 10.1161/HYPERTENSIONAHA.109.139816